Novel crystal of (S)-(+)-2-(2-chlorophenyl)-2-hydroxy-et hyl carbamate

Details for Australian Patent Application No. 2007322339 (hide)

Owner Transform Pharmaceuticals, Inc.

Inventors Tauber, Michael

Agent Shelston IP

Pub. Number AU-A-2007322339

PCT Pub. Number WO2008/063284

Priority 60/828,785 10.10.06 US

Filing date 5 October 2007

Wipo publication date 29 May 2008

International Classifications

A01N 47/10 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid - Carbamic acid derivatives, i.e. containing the group OCON

A61K 31/27 (2006.01)

A61K 31/325 (2006.01) - Carbamic acids

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/063284 Priority application(s): WO2008/063284

14 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007322340-Process for making titanium dioxide

2007322334-Method of drug delivery for bone anabolic protein